1.
Deprest J, Ghidini A, Van Mieghem T, Bianchi DW, Faas B, Chitty LS. In case you missed it: the editors bring you the most significant advances of 2015. Prenatal Diagnosis. 2016;36(1):3-9. doi:10.1002/pd.4758
2.
Smith NC, Smith APM, Smith NC. Obstetric and Gynaecological Ultrasound Made Easy. 2nd ed. Elsevier Churchill Livingstone; 2006.
3.
Pandya PP, Wapner R, Oepkes D, Sebire NJ, eds. Fetal Medicine: Basic Science and Clinical Practice. Third edition. Elsevier; 2020. https://www.sciencedirect.com/science/book/9780702069567
4.
Sadler TW. Langman’s Medical Embryology. Thirteenth edition, International edition. Wolters Kluwer; 2015.
5.
Baillière’s Clinical Obstetrics and Gynaecology. 1987;1(3). http://www.sciencedirect.com/science/journal/09503552/1/3
6.
Milunsky A, Milunsky JM, eds. Genetic Disorders and the Fetus. John Wiley & Sons Ltd.; 2021. doi:10.1002/9781119676980
7.
Simpson JL, Elias S. Essentials of Prenatal Diagnosis. Churchill Livingstone; 1993.
8.
Harrison MR, Golbus MS, Filly RA, Harrison MR. The Unborn Patient: The Art and Science of Fetal Therapy. 3rd ed. Saunders; 2001.
9.
Chudleigh P, Thilaganathan B. Obstetric Ultrasound: How, Why and When. 3rd ed. Elsevier Churchill Livingstone; 2004.
10.
Abramsky L, Chapple J. Prenatal Diagnosis: The Human Side. 2nd ed. Nelson Thornes; 2003.
11.
International Society for Prenatal Diagnosis. Prenatal diagnosis. Wiley medical publication. http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%291097-0223/issues
12.
International Fetal Medicine and Surgery Society. Fetal diagnosis and therapy. http://www.karger.com/Journal/Home/224239
13.
European Society of Human Genetics. European journal of human genetics: EJHG. http://www.nature.com/ejhg/archive/index.html
14.
Journal of Prenatal Medicine. https://www.degruyter.com/journal/key/jpme/html?lang=en
15.
PloS one. https://journals.plos.org/plosone/
16.
American Association for Clinical Chemistry. Clinical chemistry. http://www.clinchem.org/content/by/year
17.
Journal of Medical Ethics. Published online 1975. http://www.jstor.org/journal/jmedethics
18.
Massachusetts Medical Society. The New England journal of medicine. http://www.nejm.org/medical-index
19.
Wald NJ, Bestwick JP. Performance of antenatal reflex DNA screening for Down’s syndrome. Journal of Medical Screening. 2015;22(4):168-174. doi:10.1177/0969141315581005
20.
nipd_june_2016.pdf. http://www.labs.gosh.nhs.uk/media/764057/nipd_june_2016.pdf
21.
Chitty LS, van der Schoot CE, Hahn S, Avent ND. SAFE—TheSpecial Non-invasiveAdvances inFetal and NeonatalEvaluation Network: aims and achievements. Prenatal Diagnosis. 2008;28(2):83-88. doi:10.1002/pd.1929
22.
Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update. 2008;15(1):139-151. doi:10.1093/humupd/dmn047
23.
Hill M, Barrett AN, White H, Chitty LS. Uses of cell free fetal DNA in maternal circulation. Best Practice & Research Clinical Obstetrics & Gynaecology. 2012;26(5):639-654. doi:10.1016/j.bpobgyn.2012.03.004
24.
Sparks AB, Wang ET, Struble CA, Et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis. 2012;32(1):3-9. doi:10.1002/pd.2922
25.
Barrett AN, McDonnell TCR, Chan KCA, Chitty LS. Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia. Clinical Chemistry. 2012;58(6):1026-1032. doi:10.1373/clinchem.2011.178939
26.
Bianchi DW, Platt LD, Goldberg JD, Et al. Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing. Obstetrics & Gynecology. 2012;119(5):890-901. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00006250-201205000-00004&LSLINK=80&D=ovft
27.
Ravitsky V. Non-invasive prenatal diagnosis: an ethical imperative. Nature Reviews Genetics. 2009;10(10):733-733. doi:10.1038/nrg2631-c1
28.
Benn PA. Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis. JAMA. 2009;301(20). doi:10.1001/jama.2009.707
29.
Deans Z, Clarke AJ, Newson AJ. For Your Interest? The Ethical Acceptability of Using Non-Invasive Prenatal Testing to Test ‘Purely for Information’. Bioethics. 2015;29(1):19-25. doi:10.1111/bioe.12125
30.
Agathokleous M, Chaveeva P, Poon LCY, Et al. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound in Obstetrics & Gynecology. 2013;41(3):247-261. doi:10.1002/uog.12364
31.
Celik E, To M, Poon LCY, Et al. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound in Obstetrics and Gynecology. 2008;31(5):549-554. doi:10.1002/uog.5333
32.
Gallo D, Poon LC, Fernandez M, Et al. Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy. 2014;36(1):28-37. doi:10.1159/000360287
33.
Gallo DM, Poon LC, Akolekar R, Et al. Prediction of Preeclampsia by Uterine Artery Doppler at 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy. 2013;34(4):241-247. doi:10.1159/000356171
34.
Nicolaides KH. Turning the Pyramid of Prenatal Care. Fetal Diagnosis and Therapy. 2011;29(3):183-196. doi:10.1159/000324320
35.
Syngelaki A, Chelemen T, Dagklis T, Et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenatal Diagnosis. 2011;31(1):90-102. doi:10.1002/pd.2642
36.
Syngelaki A, Pergament E, Homfray T, Et al. Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities. Fetal Diagnosis and Therapy. 2014;35(3):174-184. doi:10.1159/000358388
37.
Alessandra Cacciatore. Obstetric management in Rh alloimmunizated pregnancy. Journal of Prenatal Medicine. 2009;3(2). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279102/
